Sunrise
Brussels
About Sunrise
Sunrise aims to bring simple answers to millions of people suffering from sleep disorders. We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate as in-lab sleep studies, at a fraction of the cost. Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases. Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $55.6M
- Last round: Series Unknown (Sep 2025)
- Website: hellosunrise.com
- Phone: [email protected]
Industries & Categories
Health Care, Health Diagnostics, Home Health Care, Lifestyle, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/sunrise-75534 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.